MedPath

Effect Analysis of Neoadjuvant Chemoradiotherapy Combined With Surgery in Laparoscope for Advanced Colon Cancer

Active, not recruiting
Conditions
Colon Neoplasm
Interventions
Radiation: Short-term neoadjuvant chemoradiotherapy
Registration Number
NCT05279612
Lead Sponsor
Tang-Du Hospital
Brief Summary

In this study, a randomized controlled trial was conducted on advanced colon cancer patients with preoperative tumor staging T1-4/N1-2/M0 or T4/N0/M0 to determine the effectiveness of preoperative short-term radiotherapy combined with chemotherapy and whether it can effectively reduce the postoperative local recurrence rate, so as to provide better treatment for colon cancer patients and improve the oncological treatment effect of colon cancer.

Detailed Description

This is prospective,a single-arm, single center, clinical trail study.The patient entered the study after meeting that criteria.The ORR, R0 resection, OS and DFS of patients and neoplasm down-staging status,etc would be compared.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
177
Inclusion Criteria
  • Diagnosis of colon neoplasm
  • 18 years to 70 years
  • Preoperative abdominal enhanced CT or MRI showed cT4, cN0-2
  • ECOGS score≤2
  • thoraco-abdomina CT showed no obvious metastasis(The CT of liver and lung show uncertainty tubercle,suggestive performed PET-CT) cT4,cN0-2,M0 radiography Inclusion Criteria(according postoperative enhanced CT or MRI)
  • progress tubercle penetrate peritoneotome base
  • progress tubercle penetrate serous surface of neighboring organ
  • progress tubercle development by late mesentery or side abdominis
Exclusion Criteria
  • Appeared other system cancer
  • Patient with postoperative recurrent of colon cancer
  • Patient with malignancies history in recent 5 years
  • Pregnant or female of suckle period
  • The patient have adjuvant radiotherapy record in other system cancer before this time treatment,and Patient with surgical contraindications.
  • The patient have accepted adjuvant chemoradiotherapy before this time treatment.
  • Distant metastasis found during surgery
  • Patients with poor radiotherapy compliance and difficulty in coordination
  • Patients with mental disorders

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
neoadjuvant chemoradiotherapy groupShort-term neoadjuvant chemoradiotherapypreoperative 1 circle chemotherapy(CapeOX) combined with short-course radiotherapy ,Surgical treatment(CME+D3) after four weeks of 2 circle chemotherapy(CapeOX).
Primary Outcome Measures
NameTimeMethod
Investigate patients ORR7 days after surgery

Investigate patients ORR(objective response rate ) include CR(complete response) and PR(partial response)

Secondary Outcome Measures
NameTimeMethod
neoplasm down-staging statusone month after surgery

Observation of neoplasm down-staging status in patients according to RECIST 1.1

R0 resectionimmediately after surgery

R0 resection indicates a microscopically margin-negative resection,in which no gross or microscopic tumor remains in the primary tumor bed

Quality of life scoreone month after surgery

Investigate postoperative Quality of life in patients after surgery

Investigate operation safety scoreone month after surgery

Operation safety reference Clavien degree of postoperative complication

local recurrent rate of neoplasm2 years after surgery

Observation local recurrent rate of neoplasm in patients

Investigate patience pRR (pathologic response rate)7 days after surgery

According to the English version of the Japanese Gastric Cancer Classification (JCGC) 3rd edition, pRR is defined as survival of tumor cells remaining in less than 2/3 of the tumor area (level Ib or higher)

Trial Locations

Locations (1)

General Surgery Gastrointestinal Department,Tang-Du of Fourth Military Medical University

🇨🇳

Xi'an, Shanxi, China

© Copyright 2025. All Rights Reserved by MedPath